Baxter Revenue 2010-2025 | BAX

Baxter annual/quarterly revenue history and growth rate from 2010 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
  • Baxter revenue for the quarter ending March 31, 2025 was $2.625B, a 5.42% increase year-over-year.
  • Baxter revenue for the twelve months ending March 31, 2025 was $10.771B, a 15.36% increase year-over-year.
  • Baxter annual revenue for 2024 was $10.636B, a 2.66% increase from 2023.
  • Baxter annual revenue for 2023 was $10.36B, a 3.01% increase from 2022.
  • Baxter annual revenue for 2022 was $10.057B, a 17.2% decline from 2021.
Baxter Annual Revenue
(Millions of US $)
2024 $10,636
2023 $10,360
2022 $10,057
2021 $12,146
2020 $11,673
2019 $11,362
2018 $11,099
2017 $10,584
2016 $10,163
2015 $9,968
2014 $10,719
2013 $9,413
2012 $13,936
2011 $13,893
2010 $12,843
2009 $12,562
Baxter Quarterly Revenue
(Millions of US $)
2025-03-31 $2,625
2024-12-31 $1,635
2024-09-30 $2,699
2024-06-30 $3,812
2024-03-31 $2,490
2023-12-31 $541
2023-09-30 $2,599
2023-06-30 $3,707
2023-03-31 $3,513
2022-12-31 $-853
2022-09-30 $3,609
2022-06-30 $3,594
2022-03-31 $3,707
2021-12-31 $2,876
2021-09-30 $3,226
2021-06-30 $3,098
2021-03-31 $2,946
2020-12-31 $3,181
2020-09-30 $2,972
2020-06-30 $2,718
2020-03-31 $2,802
2019-12-31 $3,039
2019-09-30 $2,851
2019-06-30 $2,834
2019-03-31 $2,638
2018-12-31 $2,819
2018-09-30 $2,761
2018-06-30 $2,842
2018-03-31 $2,677
2017-12-31 $2,797
2017-09-30 $2,707
2017-06-30 $2,605
2017-03-31 $2,475
2016-12-31 $2,645
2016-09-30 $2,558
2016-06-30 $2,585
2016-03-31 $2,375
2015-12-31 $2,603
2015-09-30 $2,487
2015-06-30 $2,475
2015-03-31 $2,403
2014-12-31 $2,789
2014-09-30 $2,709
2014-06-30 $4,154
2014-03-31 $3,848
2013-12-31 $4,322
2013-09-30 $3,710
2013-06-30 $3,669
2013-03-31 $3,448
2012-12-31 $3,499
2012-09-30 $3,477
2012-06-30 $3,572
2012-03-31 $3,388
2011-12-31 $3,594
2011-09-30 $3,479
2011-06-30 $3,536
2011-03-31 $3,284
2010-12-31 $3,498
2010-09-30 $3,224
2010-06-30 $3,194
2010-03-31 $2,927
2009-12-31 $3,470
2009-09-30 $3,145
2009-06-30 $3,123
2009-03-31 $2,824
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $14.312B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $209.668B 24.59
Boston Scientific (BSX) United States $154.824B 38.76
Stryker (SYK) United States $148.439B 31.04
EssilorLuxottica (ESLOY) France $131.494B 0.00
Medtronic (MDT) Ireland $114.826B 16.28
Lonza Group Ag (LZAGY) Switzerland $49.743B 0.00
Haleon (HLN) United Kingdom $43.081B 24.59
ResMed (RMD) United States $37.598B 28.24
GE HealthCare Technologies (GEHC) United States $34.909B 16.57
Agilent Technologies (A) United States $33.054B 21.55
Terumo (TRUMY) Japan $24.345B 31.62
Koninklijke Philips (PHG) Netherlands $23.697B 16.63
Insulet (PODD) United States $19.948B 78.30
Zimmer Biomet Holdings (ZBH) United States $18.776B 12.06
Smith & Nephew SNATS (SNN) United Kingdom $13.087B 0.00
Sunny Optical Technology (SNPTF) China $10.417B 0.00
Demant (WILYY) Denmark $8.633B 0.00
Bio-Rad Laboratories (BIO) United States $6.794B 23.64
Lantheus Holdings (LNTH) United States $5.092B 12.85
Perrigo (PRGO) Ireland $3.733B 9.46
Prestige Consumer Healthcare (PBH) United States $3.713B 16.58
Haemonetics (HAE) United States $3.529B 16.07
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.347B 27.82
ICU Medical (ICUI) United States $3.070B 22.64
LeMaitre Vascular (LMAT) United States $1.855B 41.47
QuidelOrtho (QDEL) United States $1.804B 12.41
AtriCure (ATRC) United States $1.473B 0.00
Acuren (TIC) United States $1.444B 0.00
AdaptHealth (AHCO) United States $1.242B 12.60
Green Thumb Industries (GTBIF) United States $1.207B 27.14
Phibro Animal Health (PAHC) United States $1.205B 15.40
Neogen (NEOG) United States $1.055B 13.50
BioLife Solutions (BLFS) United States $1.025B 0.00
InMode (INMD) Israel $0.891B 8.98
Kestra Medical Technologies (KMTS) United States $0.845B 0.00
Curaleaf Holdings (CURLF) Canada $0.674B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.639B 0.00
Owens & Minor (OMI) United States $0.617B 5.12
Tilray Brands (TLRY) Canada $0.615B 0.00
Evolus (EOLS) United States $0.602B 0.00
CeriBell (CBLL) United States $0.565B 0.00
Valneva SE (VALN) France $0.553B 0.00
Surmodics (SRDX) United States $0.438B 0.00
SNDL (SNDL) Canada $0.410B 0.00
Capricor Therapeutics (CAPR) United States $0.327B 0.00
VAREX IMAGING (VREX) United States $0.323B 11.89
Sanuwave Health (SNWV) United States $0.321B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.304B 0.00
Quanterix (QTRX) United States $0.275B 0.00
Cresco Labs (CRLBF) United States $0.270B 0.00
Viemed Healthcare (VMD) United States $0.264B 22.23
Cerus (CERS) United States $0.262B 0.00
Aurora Cannabis (ACB) Canada $0.256B 75.83
OraSure Technologies (OSUR) United States $0.245B 0.00
Sanara MedTech (SMTI) United States $0.244B 0.00
ZimVie (ZIMV) United States $0.241B 10.96
Biote (BTMD) United States $0.228B 6.42
Brainsway (BWAY) Israel $0.219B 58.05
Verano Holdings (VRNOF) United States $0.204B 0.00
Canopy Growth (CGC) Canada $0.204B 0.00
Omeros (OMER) United States $0.204B 0.00
High Tide (HITI) Canada $0.203B 0.00
Organigram Global (OGI) Canada $0.196B 0.00
Utah Medical Products (UTMD) United States $0.182B 14.82
TriSalus Life Sciences (TLSI) United States $0.179B 0.00
Exagen (XGN) United States $0.153B 0.00
Vireo Growth (VREOF) United States $0.150B 0.00
FitLife Brands (FTLF) United States $0.125B 15.33
TerrAscend (TSNDF) Canada $0.107B 0.00
Jin Medical (ZJYL) China $0.101B 0.00
Fonar (FONR) United States $0.099B 12.74
MacroGenics (MGNX) United States $0.097B 0.00
Veru (VERU) United States $0.090B 0.00
Quipt Home Medical (QIPT) United States $0.090B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
Apyx Medical (APYX) United States $0.086B 0.00
Jushi Holdings (JUSHF) United States $0.081B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Agape ATP (ATPC) $0.071B 0.00
InterCure (INCR) Israel $0.068B 0.00
Cytosorbents (CTSO) United States $0.062B 0.00
ImmuCell (ICCC) United States $0.060B 0.00
Safety Shot (SHOT) United States $0.052B 0.00
United-Guardian (UG) United States $0.042B 14.54
Nephros (NEPH) United States $0.038B 51.14
Modular Medical (MODD) United States $0.038B 0.00
Rockwell Medical (RMTI) United States $0.037B 0.00
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.016B 0.00
Flora Growth (FLGC) United States $0.014B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Senestech (SNES) United States $0.011B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
Sharps Technology (STSS) United States $0.006B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00